Europe Veterinary Diagnostics Market

Europe Veterinary Diagnostics Market (2022 to 2027)

The Europe Veterinary Diagnostics Market has seen an exemplar shift in the past few years with the emergence of new and technologically advanced products, which had an optimistic impact on the market's overall growth.

The European Parliament and the Council adopted the Regulation on transmissible animal diseases (“Animal Health Law”) in March 2016. The regulation will be applicable in the next five years. It’ll support the EU livestock sector in its quest towards competitiveness and a safe and smooth EU market of animals and their products, creating growth for the veterinary diagnostics market. Veterinary diagnostic products are as complex as they are challenging to manufacture. Many of the poultry and livestock diagnostic products are biological products that demand materials from living organisms. Market development for companion animal diagnostic has depended heavily upon the purchasing and using in-clinic analyzers or diagnostic instruments used at veterinary practices.

Factors such as growing Zoonotic diseases in animals, increasing the number of veterinary practitioners in Europe, and increasing the demand for animal protein are primarily driving the veterinary diagnostics market in Europe. Growing technological support to diagnose animal diseases, increasing product launches, and rising partnerships between major companies are propelling the market growth. In addition, rising per capita income in Europe, growing awareness among pet owners regarding their pet animal’s health, and an increasing number of in-clinical diagnostic methods are forecasted to boost the market.

The high costs associated with veterinary diagnostics and the restorative steps for animal diseases are expected to restrain the market.

This research report on the European veterinary diagnostics market has been segmented and sub-segmented into the following categories:

By Product Type: 

• Clinical Chemistry
  • Urine Analysis
  • Glucose Monitoring
  • Blood Gas Electrolyte Analysis
• Molecular Diagnostics        
  • Micro Arrays
  • PCR Tests
  • Other Molecular Diagnostics Tests
• Hematology         
  • Hematology Analysers
  • Hematology Cartridges
• Diagnostic Imaging              
  • Radiography Systems
  • Ultrasound Imaging Systems
  • CT Scanners
  • MRI Scanners
• Immunodiagnostics            
  • Immunoassay Analysers
  • ELISA Tests
  • Lateral-Flow Strip Readers
  • Lateral-Flow Rapid Tests
  • Allergen-specific Immunodiagnostic Tests

By Animals: 

• Companion Animals            
  • Canine Diagnostics
  • Feline Diagnostics
  • Other Veterinary Diagnostics
• Food-Producing Animals   
  • Bovine Diagnostics
  • Porcine Diagnostics
  • Ovine Diagnostics
  • Poultry Diagnostics
  • Piscine Diagnostics

By Country: 

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

The European Veterinary Diagnostics Market was accounted for the second-largest share in the global market in 2020. It is further predicted to be growing at a robust CAGR during the forecast period. The UK market for veterinary diagnostics is projected to be the accounting largest share in the European market during the forecast period due to the growing expenditure on pets. Increasing importance to prevent and control zoonotic animal diseases straight away from the human population across Europe and growing demand for pet insurance, an increasing number of veterinary clinics are driving the market. The German veterinary diagnostics market is forecasted to hike at a healthy rate during the forecast period due to rising animal healthcare expenditure, growing pet adoption, and increasing demand for animal-derived food products. Other countries such as France, Italy, and Spain are expected to have a considerable share during the forecast period.

KEY MARKET PLAYERS:

A few noteworthy companies operating in the European veterinary diagnostics market profiled in this report are VCA Inc., Heska Corporation, Abaxis Inc., VIRBAC, IDEXX Laboratories Inc., Life Technologies Corporation, Bio-Rad Laboratories Inc., Prionics AG, and Pfizer. Inc.